926027

NanoFabTX™-DOTAP Lipid Mix

for synthesis of cationic (DOTAP) liposomes

Manufacturer: Sigma Aldrich

Synonym(S): Drug delivery, LNP, Microfluidics, NanoFab reagent kit, Nanoformulation, Nanoparticle

Select a Size

Pack Size SKU Availability Price
50 MG 926027-50-MG In Stock ₹ 27,450.00

926027 - 50 MG

₹ 27,450.00

In Stock

Quantity

1

Base Price: ₹ 27,450.00

GST (18%): ₹ 4,941.00

Total Price: ₹ 32,391.00

Quality Level

100

storage temp.

−20°C

Related Products

Img

Sigma Aldrich

926345

for synthesis of cationic (DC-chole...

Img

Sigma Aldrich

930113

for synthesis of carboxyl functiona...

Img

Sigma Aldrich

934194

--

Img

Sigma Aldrich

934208

--

Img

Sigma Aldrich

934216

--

Img

Sigma Aldrich

937231

--

Img

Sigma Aldrich

922420

for synthesis of PEGylated liposome...

Img

Sigma Aldrich

937266

--

Description

  • General description: NanoFabTx™-DOTAP Lipid Mix includes reagents and optimized protocols with step-by-step instructions for synthesizing cationic liposomes for drug delivery research applications. The modification of liposomes with the cationic lipid, DOTAP, have numerous advantages such as their large-DNA incorporation, high transfection efficiency, and low toxicity. Liposome-based formulations are widely used for drug delivery applications and enable improved therapeutic efficacy of a range of drug types including small molecules, nucleic acids, proteins, and peptides. Comprehensive protocols for liposome synthesis are included:A lipid film hydration and extrusion protocol. A microfluidics protocol using commercial platforms or syringe pumps. The microfluidics protocol included with this product uses NanoFabTx™ device kits (911593). These kits come with the microfluidics chips, fittings, and tubing required to get started with microfluidics-based synthesis (compatible microfluidics system or syringe pump required).
  • Application: NanoFabTx™-DOTAP Lipid Mix is a ready-to-use nanoformulation blend for the synthesis of cationic DOTAP-functionalized liposomes. This kit enables users to encapsulate a wide variety of therapeutic drug molecules for targeted or extended drug delivery without the need for lengthy trial-and-error optimization. NanoFabTx™ kits provide an easy-to-use toolkit for encapsulating a variety of therapeutics in nanoparticles, microparticles, or liposomes. Drug encapsulated particles synthesized with the NanoFabTx™ kits are suitable for biomedical research applications such as oncology, immuno-oncology, gene delivery, and vaccine delivery.
  • Features and Benefits: A ready-to-use nanoformulation blend for the synthesis of cationic liposomes Step-by-step protocols (extrusion or microfluidic) developed and tested by our formulation scientistsFlexible synthesis tools to create uniform and reproducible liposomesOptimized to make liposomes around 100 nm with low polydispersityDOTAP surface-functionalized allows for targeting ligand conjugation to enable targeted drug delivery
  • Legal Information: NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

SAFETY INFORMATION

WGK

WGK 3

Compare Similar Items

Show Difference

Img

Sigma Aldrich

926027

for synthesis of cationic (DOTAP) l...


Quality Level:
100

storage temp.:
−20°C

Img

Sigma Aldrich

926035

--


Quality Level:
100

storage temp.:
__

Img

Sigma Aldrich

926051

UV/365 nm, low endotoxin...


Quality Level:
100

storage temp.:
__

Img

Sigma Aldrich

926078

Vis/405 nm, low endotoxin...


Quality Level:
100

storage temp.:
__